Capsule Endoscopy for Obscure Gastrointestinal Bleeding in Patients with Comorbid Rheumatic Diseases

Table 2

Comorbid diseases of included cases.

Characteristics	Negative CE (𝑁=16)		Positive CE (𝑁=25)		𝑃 value	RHEUM CE (𝑁=41)		Non-RHEUM CE (𝑁=627)		𝑃 value
	𝑁 (%)	SD	𝑁 (%)	SD		𝑁 (%)	SD	𝑁 (%)	SD
Myocardial infarction history	1 (6.3)		1 (4.0)		1.000	2 (4.9)		45 (7.2)		0.760
Congestive heart failure	0 (0)		1 (4.0)		1.000	1 (2.4)		59 (9.4)		0.164
Peripheral vascular disease	2 (12.5)		1 (4.0)		0.550	3 (7.3)		26 (4.2)		0.413
Cerebrovascular disease	1 (6.3)		1 (4.0)		1.000	2 (4.9)		47 (7.5)		0.760
Dementia	0 (0)		0 (0)		1.000	0 (0)		3 (0.5)		1.000
Chronic pulmonary disease	3 (18.8)		3 (12.0)		0.662	6 (14.6)		66 (10.5)		0.432
History of ulcer disease	2 (12.5)		2 (8.0)		0.637	4 (9.8)		53 (8.5)		0.771
Mild liver disease	0 (0)		4 (16.0)		0.143	4 (9.8)		21 (3.4)		0.060
Diabetes w/o end-organ damage	2 (12.5)		3 (12.0)		1.000	5 (12.2)		100 (16.0)		0.522
Hemiplegia or paraplegia	0 (0)		0 (0)		1.000	0 (0)		3 (0.5)		1.000
Diabetes w/end-organ damage	1 (6.3)		4 (16.0)		0.632	5 (12.2)		48 (7.7)		0.362
Moderate-severe renal disease	1 (6.3)		5 (20.0)		0.376	6 (14.6)		60 (9.6)		0.280
Any tumor	3 (18.8)		4 (16.0)		1.000	7 (17.1)		96 (15.3)		0.762
Leukemia	0 (0)		0 (0)		1.000	0 (0)		5 (0.8)		1.000
Lymphoma	0 (0)		1 (4.0)		1.000	1 (2.4)		10 (1.6)		0.505
Moderate-severe liver disease	0 (0)		1 (4.0)		1.000	1 (2.4)		11 (1.8)		0.535
Metastatic solid tumor	0 (0)		0 (0)		1.000	0 (0)		7 (1.1)		1.000
AIDS	0 (0)		0 (0)		1.000	0 (0)		0 (0)		1.000
Mean Charlson index	2.31	1.54	2.88	1.56	0.258	2.66	1.56	1.50	1.93	<0.001

AIDS: acquired immunodeficiency syndrome.